Precise Cancer Care with Targeted Therapy in Delhi at LYFE Medicare Cancer Centre
At LYFE Medicare Cancer Centre in Delhi, cancer care has reached new heights with the introduction of Targeted Therapy for Cancer in Delhi, a revolutionary approach that focuses on precision and personalized treatment. This advanced therapy method has transformed the way certain cancers are treated, offering new hope to patients who require more specialized care compared to traditional chemotherapy or radiation.
At LYFE Medicare Cancer Centre, Targeted Therapy in Delhi is tailored to the individual patient’s unique cancer profile. Using advanced genomic and molecular testing, our oncology team can detect mutations and specific biomarkers present in each tumor. This allows us to select drugs that target these abnormalities directly, making the treatment more effective and less harmful to surrounding healthy cells.
-
Breast Cancer (HER2-positive)
-
Lung Cancer (EGFR, ALK mutations)
-
Colorectal Cancer (KRAS, BRAF mutations)
-
Melanoma (BRAF mutation)
-
Certain Types of Leukemia and Lymphoma
Patients who undergo genomic profiling can significantly benefit from this personalized treatment plan, resulting in better disease control, fewer side effects, and an improved quality of life.
- Personalized Treatment: Every treatment plan is crafted based on the specific genetic makeup of the patient’s cancer.
- Advanced Genomic Testing: Helps identify the exact mutations responsible for tumor growth.
- Minimized Side Effects: Compared to traditional therapies, targeted therapy spares more healthy tissues.
- Enhanced Outcomes: Studies show better survival rates and disease-free periods for patients receiving targeted treatments.
- Experienced Oncologists: Our cancer specialists are trained in the latest protocols for delivering targeted therapy safely and effectively.
Comments